Safety and Efficacy of Different Dose Levels of Pasireotide in Patients With de Novo, Persistent or Recurrent Cushing's Disease

Novartis Investigative Site, Edegem

Novartis Investigative Site, Aarhus

Novartis Investigative Site, Ghent

Columbia University Medical Center- New York Presbyterian Columbia University DeptofMed, New York

Novartis Investigative Site, Orbassano

Novartis Investigative Site, Berlin

Novartis Investigative Site, Torino

Novartis Investigative Site, Marseille

Novartis Investigative Site, Mexico City

Novartis Investigative Site, Milan

Novartis Investigative Site, Milan

Novartis Investigative Site, Toulouse

Novartis Investigative Site, Pessac

Novartis Investigative Site, Fatih / Istanbul

Novartis Investigative Site, Padua

Novartis Investigative Site, Haifa

Novartis Investigative Site, Balcova / Izmir

Novartis Investigative Site, Grenoble Cédex 9

Novartis Investigative Site, Seville

Novartis Investigative Site, Saint-Priest-en-Jarez

Novartis Investigative Site, Cona

Cleveland Clinic Foundation Dept. of Cleveland Clinic (6), Cleveland

Novartis Investigative Site, Essen

Novartis Investigative Site, Angers

Novartis Investigative Site, Petah Tikva

Novartis Investigative Site, Pisa

Novartis Investigative Site, Lille

Novartis Investigative Site, Ancona

University Chicago Hospital Dept. of Univ of Chicago, Chicago

Novartis Investigative Site, Paris

Baylor College of Medicine, Houston

Novartis Investigative Site, Napoli

Novartis Investigative Site, München

Novartis Investigative Site, Limoges

Stanford University Medical Center Stanford Cancer Center (3), Stanford

Novartis Investigative Site, Würzburg

Oregon Health & Sciences University Dept.ofOregonHealth&SciencesU., Portland

Novartis Investigative Site, Beijing

Novartis Investigative Site, Beijing

Novartis Investigative Site, Shanghai

Novartis Investigative Site, Haifa

Novartis Investigative Site, Jerusalem

Dana Farber Cancer Institute The Melanoma Program, Boston

University of Texas Southwestern Medical Center Clinical-TranslationalRes.Ctr., Dallas

University of Texas/MD Anderson Cancer Center Dept.ofMDAndersonCancerCtr(8), Houston

Swedish Medical Center Dept.ofSeattle Neuroscience(2), Seattle

Novartis Investigative Site, Buenos Aires

Novartis Investigative Site, Buenos Aires

Novartis Investigative Site, Capital Federal

Novartis Investigative Site, Curitiba

Novartis Investigative Site, Rio de Janeiro

Novartis Investigative Site, Porto Alegre

Novartis Investigative Site, Ribeirão Preto

Novartis Investigative Site, São Paulo

Novartis Investigative Site, São Paulo

Novartis Investigative Site, Edmonton

Novartis Investigative Site, Halifax

Novartis Investigative Site, Montreal

Novartis Investigative Site, Copenhagen

Novartis Investigative Site, Herlev

Novartis Investigative Site, Helsinki

Novartis Investigative Site, Athens

Novartis Investigative Site, Athens

Novartis Investigative Site, Mexico City

Novartis Investigative Site, Warsaw

Novartis Investigative Site, Porto

Novartis Investigative Site, Barcelona

Novartis Investigative Site, Ankara